|

Platinum Compound Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Platinum Agents, Platinum-Based Chemotherapeutic Agent

Pipeline

Phase 2: 1

Top Sponsors

  • SWOG Cancer Research Network1

Indications

  • Lung Small Cell Carcinoma, P Subtype1
  • Lung Small Cell Carcinoma, N Subtype1
  • Lung Small Cell Carcinoma, I Subtype1
  • Lung Small Cell Carcinoma, A Subtype1
  • Extensive Stage Lung Small Cell Carcinoma1

Newark, Delaware1 trial

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Helen F Graham Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.